Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and. at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine.  He then undertook a research degree from the University of Birminghan, UK which led to the award of an MD.  He pioneered the development of a continuous blood gas monitoring system which reached clinical application.

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014-2016.  He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy.

He led the NHMRC funded multi-center international ADRENAL trial which is largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several  Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state, sepsis and vitamin D in critical illness.

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute’s Covid-19 research program in India and played a  key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock.

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow.

After completion of her Masters, Sudha started her career in clinical research at Clinigene International Ltd, sister concerns of Biocon. She has worked in clinical research industry for the past five and a half years and was part of George Clinical for nearly four years.

Sudha has had experience in working on academic trials and seeks to pursue higher education and training in public health research, especially in the areas of non-communicable diseases including mental health and injuries.

She is currently involved in a study where mobile-based technology is being used to provide basic mental health care to scheduled tribe villages in rural Andhra Pradesh. 

Pallab leads Research department at The George Institute for Global Health, India. He trained as a psychiatrist at All India Institute of Medical Sciences, New Delhi, received training in public health at the London School of Hygiene and Tropical Medicine, as well as Johns Hopkins School of Public Health where he pursued his Masters and Doctoral training, respectively.

Professor Maulik has worked with the World Health Organisation (WHO), Geneva on Project Atlas and other mental health programs, and clinically as a psychiatrist in India and Australia. He has worked for more than 25 years in global mental health and has research network across multiple countries and institutions where he is affiliated with and with whom he collaborates on many projects.  

His particular research interests include social determinants of health, especially mental health services, mental disorders, international mental health, and intellectual disability. He is a Principal Investigator or co-investigator on many large mental health projects in India and abroad. He primarily focuses on delivering affordable and accessible mental health care for disadvantaged and marginalized communities in India, while using technology-enabled solutions to enable the health system to function more efficiently. He also leads a significant programme of work on stigma related to mental health. He was an Intermediate Career Wellcome Trust/DBT India Alliance Fellow from 2014-19 and currently is a Senior Fellow of the Wellcome Trust/DBT India Alliance.